No abstract available
MeSH terms
-
Amoxapine / pharmacology
-
Amoxapine / therapeutic use
-
Animals
-
Antidepressive Agents, Second-Generation / pharmacology
-
Antidepressive Agents, Second-Generation / therapeutic use
-
Brain / metabolism
-
Humans
-
Ligands
-
Membrane Glycoproteins / metabolism
-
Membrane Glycoproteins / physiology*
-
Membrane Transport Proteins / metabolism
-
Membrane Transport Proteins / physiology*
-
Mood Disorders / drug therapy
-
Mood Disorders / etiology*
-
Mood Disorders / metabolism
-
Nerve Tissue Proteins / metabolism
-
Nerve Tissue Proteins / physiology*
-
Paroxetine / pharmacology
-
Paroxetine / therapeutic use
-
Receptor, Serotonin, 5-HT1A / metabolism
-
Receptor, Serotonin, 5-HT1A / physiology*
-
Receptors, Dopamine D1 / metabolism
-
Receptors, Dopamine D1 / physiology*
-
Receptors, Serotonin, 5-HT2 / metabolism
-
Receptors, Serotonin, 5-HT2 / physiology*
-
Selective Serotonin Reuptake Inhibitors / therapeutic use
-
Serotonin Plasma Membrane Transport Proteins
-
Trazodone / pharmacology
-
Trazodone / therapeutic use
Substances
-
Antidepressive Agents, Second-Generation
-
Ligands
-
Membrane Glycoproteins
-
Membrane Transport Proteins
-
Nerve Tissue Proteins
-
Receptors, Dopamine D1
-
Receptors, Serotonin, 5-HT2
-
SLC6A4 protein, human
-
Serotonin Plasma Membrane Transport Proteins
-
Serotonin Uptake Inhibitors
-
Receptor, Serotonin, 5-HT1A
-
Paroxetine
-
Amoxapine
-
Trazodone